HTLV-1 gp21 Recombinant Protein (RPPB5608)
- SKU:
- RPPB5608
- Product type:
- Recombinant Protein
- Size:
- 0.5mg
- Species:
- HTLV-1
- Target:
- gp21
- Source:
- Escherichia Coli
Description
| Product Name: | HTLV-1 gp21 Recombinant Protein |
| Product Code: | RPPB5608 |
| Size: | 0.5mg |
| Species: | HTLV-1 |
| Target: | gp21 |
| Source: | Escherichia Coli |
| Formulation: | 60mM NaCl, 50mM Tris-HCl, pH-8.0, 0.25% Sarkosil, 50% Glycerol and 10mM Glutathione. |
| Stability: | HTLV-1 gp21 although stable at 4°C for 1 week, should be stored below -18°C. Please prevent freeze thaw cycles. |
| Purity: | HTLV-1 gp21 is >95% pure as determined by 10% SDS-PAGE (coomassie staining) and HPLC-C4. |
Human T-lymphotropic virus (HTLV) is a human, single-stranded RNA retrovirus that causes T-cell leukemia and T-cell lymphoma. The virus activates a subset of T-helper cellscalled Th1cells. The result is a proliferation of Th1 cells and overproduction of Th1 related cytokines (mainly IFN-gamma and TNF-alpha). Feedback mechanisms of these cytokines cause a suppression of the Th2 lymphocytes and a reduction of Th2 cytokine production (mainly IL-4, IL-5, IL-10 and IL-13). The end result is a reduction in the ability of the infected host to mount an adequate immune response to invading organisms that require a predominantly Th2 dependant response (these include parasitic infections and production of mucosal and humoral antibodies).
The E.Coli derived recombinant protein contains the gp21 immunodominant region, 351-404 amino acids, the MW is 21kDa. Fused with a GST tag at N-Terminus.
Related Products
